Learn More
Medchemexpress LLC Dasatinib monohydrate | 863127-77-9 | MFCD08704581 | 99.6% | 506.03 g/mol | C22H26ClN7O2S · H2O | 50 MG

Supplier: Medchemexpress LLC HY10181B50MG
Dasatinib monohydrate is a potent, ATP-competitive dual Src and Bcr-Abl tyrosine kinase inhibitor used in preclinical oncology research. Provided in a defined monohydrate form, it is supplied as a solid and as a DMSO solution for in vitro assay use, enabling reproducible pharmacology and biochemical studies.
- High purity: 99.6% (reported), suitable for research applications.
- Monohydrate form for defined solid-state properties and reproducible handling.
- Potent dual Src and Bcr-Abl inhibition for kinase signaling and cancer biology studies.
- Available as 50 MG solid and as a 10 mM solution in DMSO for assay flexibility.
- Molecular weight approximately 506.03 g/mol and CAS 863127-77-9 for unambiguous identification.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.